Australia's Creso Pharma surges on psychedelic supply deal with Canadian firm

Melodiol Global Health

30/05/2022 04:24

** Shares of the cannabis and hemp maker Creso Pharma  CPH.AX 
jump as much as 3.8% to A$0.055, set for their first session of
gains in five
    ** Co says its unit Halucenex Life Sciences enters supply
deal with Canadian firm that focuses on natural psychedelics'
Optimi Health  urn:newsml:reuters.com:*:nASX8GlW1K
    ** Says deal for supply of whole dried mushrooms fruiting
bodies if Optimi Health passes the initial round of tests 
    ** Says products from supply deal will be used for product
development with a focus on post-traumatic stress disorder and
anxiety 
    ** Stock down 35.4% this year as of last close, vs a 2.6%
fall in the benchmark S&P/ASX 200 index  .AXJO  


 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))